Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
PUMA BIOTECHNOLOGY, INC. (PBYI) · INSIDER
Data sources
SEC Form 4
53m ago
House PTR
52m ago
SEC 13F
52m ago
Robinhood Chain
52m ago
Public company
PUMA BIOTECHNOLOGY, INC.
PBYI
CIK 0001401667
EDGAR filings
Open in network
○
Watch PBYI
Price
$7.05
1 year
+44.2%
Disclosed transactions
1
Buys / sells
0 / 1
Max Insider Score
28
Connections with evidence
3
Customize layout
PBYI · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
28
MP
MILLER MICHAEL PATRICK
Director
PBYI
PUMA BIOTECHNOLOGY, INC.
Open-market sale
SELL
$121K
15.0K sh
Nov 11, 2026
Nov 13, 2026
Verified connections
← Holds over 5% of
evidence
American Century Investment Management, Inc.
5.3% of class · Schedule 13G · Nov 15, 2026
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 13, 2026
← Insider of
evidence
MILLER MICHAEL PATRICK
Director · Form 144 · Nov 11, 2026
traded Nov 11, 2026
+2d
SEC Form 4
Evidence
Evidence
Close
Planned sales and 5% stakes
Form 144, 13D and 13G
American Century Investment Management, Inc.
Passive holder · crossed on Sep 30, 2026 · 2.74M shares
5.3% of class
13G · filed Nov 16, 2026
MP
MILLER MICHAEL PATRICK
Director · sale around Nov 11, 2026 · 15.0K shares
$121K
Form 144 · filed Nov 12, 2026
Disclosed trades
TradingView